Drawing for OIDX

USPTO serial 87394618

OIDX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
OESTREICHER, SALIMA PARMAR
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with OIDX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Daina J. Nathanson

DAINA J. NATHANSON DRUMMOND WOODSUM84 MARGINAL WAY, SUITE 600PORTLAND, ME 04101-2480UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical preparations, biochemical preparations and biological preparations for use in measuring, testing and analyzing blood and other bodily fluids, other than for medical, clinical, pharmaceutical and veterinary use; chemical preparations, biochemical preparations and biological preparations for use in measuring, testing and analyzing water, other than for medical, clinical, pharmaceutical and veterinary use; chemical preparations, biochemical preparations and biological preparations for use in measuring, testing and analyzing air samples and soil samples other than for medical, clinical, pharmaceutical and veterinary use; and chemical reagents other than for medical, clinical, pharmaceutical and veterinary useACTIVE—
005Chemical preparations, biochemical preparations and biological preparations for use in measuring, testing and analyzing blood and other bodily fluids for the diagnosis and treatment of cardiovascular diseases, neurological diseases, oncology diseases, inflammatory diseases, auto-immune diseases, infectious diseases, metabolic diseases, gastroenterological diseases, respiratory diseases, and hematological diseases, for medical, clinical, pharmaceutical and veterinary use; chemical preparations, biochemical preparations and biological preparations for use in measuring, testing and analyzing water for sanitary purposes for medical, clinical, pharmaceutical and veterinary use; chemical reagents for medical, clinical, pharmaceutical and veterinary purposes; diagnostic test kits consisting primarily of chemical reagents for medical, clinical, pharmaceutical and veterinary purposes for use in disease testing; diagnostic test kits consisting primarily of chemical reagents for medical, clinical, pharmaceutical and veterinary purposes for use in testing for the presence of hormones, bacteria, enzymes, pathogens, metals, parasites, fungi, viruses, prions, protozoa, and multicellular organisms; diagnostic test kits consisting primarily of chemical reagents for medical, clinical, pharmaceutical and veterinary purposes and also including associated computer software with algorithms which capture, process and analyze digital images, sold as a unit for use in testing for the presence of hormones, bacteria, enzymes, pathogens, metals, parasites, fungi, viruses, prions, protozoa, and multicellular organismsACTIVE—
009Computer software with algorithms which capture, process and analyze digital imagesACTIVE—
010Medical apparatus and instruments, namely, medical diagnostic apparatus and associated computer software with algorithms which capture, process and analyze digital images, sold as a unit for testing for the presence of hormones, bacteria, enzymes, pathogens, metals, parasites, fungi, viruses, prions, protozoa, and multicellular organismsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 22, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 21, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 31, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 29, 2018EX1GSOU EXTENSION 1 GRANTED—
May 29, 2018EXT1SOU EXTENSION 1 FILED—
May 29, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 19, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 24, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 24, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 4, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 12, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 12, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Sep 12, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 12, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 12, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 4, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 4, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 3, 2017ALIEASSIGNED TO LIE—
Jul 5, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 24, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 24, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 24, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 23, 2017DOCKASSIGNED TO EXAMINER—
Apr 8, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Apr 6, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 4, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance